- A vasopressor/antihypotensive agent (α<sub>1</sub> agonist)
- Midodrine was approved by the FDA in 1996 for the treatment of dysautonomia 自主神經障礙 and orthostatic hypotension 體位性低血壓.
- In 2010, the FDA proposed withdrawing this approval
- Should not be used in patients with persistent and excessive supine hypertension 仰臥高血壓
![[Pasted image 20230406123354.png]]